Clinical trials
Myelodysplastic Syndromes trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 8 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 9 |
| Novartis Pharmaceuticals | 6 |
| SymBio Pharmaceuticals | 6 |
| Takeda | 3 |
| AbbVie | 2 |
| Boehringer Ingelheim | 2 |
| Bristol-Myers Squibb | 2 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 49 |
| Leukemia, Myeloid, Acute | 16 |
| Leukemia, Myelomonocytic, Chronic | 9 |
| Anemia | 6 |
| Multiple Myeloma | 4 |
| Hematologic Neoplasms | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Recurrence | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
Trials
Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.